Background
==========

CCR5 is expressed on Th1 cells and may play a role in Rheumatoid Arthritis by recruiting these cells to the synovium, where they drive an inflammatory process. The *CCR5*Δ32 variant, a deletion variant which leads to a dysfunctional receptor, has been reported in several genetic association studies in Juvenile Idiopathic Arthritis (JIA), with conflicting results. CCL14 is one of the ligands of CCR5 and polymorphisms in the *CCL14* gene have been reported to be associated with Systemic Lupus Erythematosus.

Aim
===

We performed a case-control genetic association study to investigate whether *CCR5* and *CCL14* polymorphisms are associated with susceptibility to JIA.

Methods
=======

*CCR5*Δ32 and *CCL14* rs16971802 were genotyped in 667 JIA cases and 1320 healthy controls, both of North-West-European white origin. Patients with oligoarticular (persistent and extended), polyarticular (rheumatoid factor negative and positive) and systemic JIA have been included. A meta-analysis combined with three published studies on *CCR5*Δ32 in JIA, with comparable allele frequencies in controls, was performed.

Results
=======

*CCR5*Δ32 and *CCL14* rs16971802 were not significantly associated with JIA in this study, with p-values of 0.12 and 0.72 respectively. Nevertheless, meta-analysis demonstrated association of *CCR5*Δ32 with protection to JIA (combined p=0.0003, OR=0.83, 95% CI: 0.75-0.91, Breslow-Day p=0.87, heterogeneity I-squared=0.0%).

Conclusion
==========

This study has not demonstrated significant associations of *CCR5* and *CCL14* polymorphisms with JIA, but the association of *CCR5*Δ32 with protection from developing JIA is strengthened in a meta-analysis. It is hypothesized that function of CCR5 could influence synovial inflammation also in JIA.
